Based on these results, we may surmise that CCL11 and IP-10 are specifically increased in plasma from pulmonary tuberculosis and tuberculous pleurisy patients, while CCL8 and CCL2 are specifically decreased when compared with lung cancer controls. Here, CCL11 is linked to lung carcinoma.